20 September, 2017
The last stock close price is down -0.79% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.04% over the same time period. The average investment rating for WBA on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 4.53 or a Moderate Buy. The firm has "Equal-Weight" rating given on Thursday, March 10 by Barclays Capital.
Walgreens Boots Alliance, Inc.is a holding company.
RBC Capital analyst has started coverage on Walgreens Boots Alliance (NASDAQ:WBA) with a $96 target price and "Outperform" rating. They issued a buy rating and a $95.00 price target for the company. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the company's stock. The company has an average rating of Buy and an average price target of $92.06.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 29th. WBA 's 20-day moving average now sits below its 100-day moving average. The financial company set "Outperform" rating on the $86.90 billion market cap company.
The share price of the company (NASDAQ:WBA) was up +0.12%, with a high of 83.62 during the day and the volume of Walgreens Boots Alliance, Inc. shares traded was 6117199.
Investors wait Walgreens Boots Alliance Inc (NASDAQ:WBA) to report on October, 19. its quarterly earnings Wall Street analysts expect $1.22 EPS, up $0.15 or 14.02 % from last year's $1.07 same quarter earnings. This is assuming the current $1.22 EPS is accurate. Last quarter, the company saw 30.12 billion in total revenues. Sell-side firms now have a consensus recommendation of 2.00 on the shares. In the most recent quarter, institutional ownership decreased by a net of 10.22 million shares, or 1.57%. (WBA) to generate earnings per share of $5.02 in 2017.
COPYRIGHT VIOLATION WARNING: This news story was first posted by BBNS and is the property of of BBNS. Originally, the company had agreed to buy Rite Aid's 4,600 stores for $17.2 billion in October 2015. Stockholders of record on Friday, August 18th were given a dividend of $0.40 per share. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%.
04/04/2017 - Pivotal Research began new coverage on Walgreens Boots Alliance, Inc. giving the company a "hold" rating. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases.
In related news, Director William C. Foote sold 2,736 shares of the company's stock in a transaction dated Tuesday, July 25th. This means that the stock's daily price swings have been less extreme in recent times compared to the past. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
02/06/2017 - Walgreens Boots Alliance, Inc. was upgraded to "overweight" by analysts at Atlantic Equities. Webster Bank N.A. boosted its stake in shares of Walgreens Boots Alliance by 18.4% in the 1st quarter. Whereas, in last 21 trading days (one month) was surged 1.47% and surged in last 63 trading days (quarter) of 3.72%. Of the analysts surveyed by Reuters that track Walgreens Boots Alliance, Inc. Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.is a holding company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.
